Charles River Laboratories Intl (CRL) Stock Price, Quote & News

Company Profile

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of serv...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 781 222 6000

Website: www.criver.com

Address:

251 Ballardvale Street, Wilmington, United States

Sam201 Feb. 2 at 2:33 PM

$CRL short more!

0 · Reply

IN0V8 Jan. 22 at 3:28 PM

$CRL TD Cowen raises target to $251 from $197

0 · Reply

IN0V8 Jan. 20 at 10:10 PM

$CRL Jefferies raises PT to $255 from $205

0 · Reply

Funxs Jan. 16 at 2:55 PM

$ZOMDF Anyone happen to look at Evan St Peter - hopefully on the 1/23 call mentioned - digital/ai/connected intelligent platforms , but more importantly he spent 9yrs at MPI Research before the co got acquired by Charles River Labs $CRL a 13 billion company and then he went to Stryker to build their connected care platform (iot/Ai/big data/machine learning and this was before anyone even knew those terms). And then he joined our .01 Zomedica - I don’t think he joined to get it to .50 etc

0 · Reply

BullishBecky Jan. 13 at 6:28 PM

$CRL

0 · Reply

IN0V8 Jan. 13 at 6:04 PM

$CRL Opportunity Baird raises target price to $231 from $224

0 · Reply

erevnon Jan. 13 at 3:49 PM

Evercore ISI Group maintains Charles River $CRL at Outperform and raises the price target from $250 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

Sam201 Jan. 8 at 3:34 PM

$CRL shorting some more.

0 · Reply

AlphaBull_10M Jan. 6 at 9:35 PM

$MSTR This is not a rumor as several main stream media is picking up the news. https://www.investing.com/news/stock-market-news/strategy-stock-surges-6-after-msci-decides-against-excluding-crypto-firms-4433541 $BTC.X $MSTU $CRL $ETH.X

0 · Reply

kareem1988 Jan. 6 at 12:33 PM

Biotechs that hit 52-week highs yesterday: $CDTX: Shares hit $221.24 following a $9.2B acquisition deal by Merck. $DRTS hit a 2-year high yesterday after submitting its first FDA PMA module for Alpha DaRT. With ASCO GI (Jan 8-10) and the JPM Healthcare Conference (Jan 15) ahead, the stock is primed for a breakout toward the $8.00 analyst target. $CRNX: Reached $55.23 on strong launch revenue and positive Phase 2 clinical data. $CRL: Hit $207.14 after a BofA upgrade to Buy with a $225 price target TASH: Touched a 1-year peak following a Goldman Sachs upgrade to an $11 target

0 · Reply

Charles River Laboratories Schedules Fourth-Quarter 2025 Earnings and 2026 Guidance Release and Conference Call

Jan 21, 2026, 8:00 AM EST - 13 days ago

Charles River Enters Manufacturing Collaboration with Gazi University

Jan 20, 2026, 3:39 PM EST - 13 days ago

Charles River Laboratories Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Charles River Laboratories International, Inc. - CRL

Jan 13, 2026, 3:55 PM EST - 20 days ago

Charles River Laboratories International, Inc. (CRL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 5:19 PM EST - 21 days ago

Charles River to buy Cambodia-based monkey supplier for $510 million

Jan 12, 2026, 4:30 PM EST - 21 days ago

Charles River Laboratories Provides Business Updates

Jan 8, 2026, 8:00 AM EST - 26 days ago

Charles River Laboratories Announces Planned Retirement of James C. Foster and CEO Succession Plan

Dec 11, 2025, 8:00 AM EST - 7 weeks ago

Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort

Dec 4, 2025, 8:30 AM EST - 2 months ago

T. Rowe Price Transitions to Charles River's Enterprise Multi-Asset Investment Management Platform

Dec 3, 2025, 12:43 PM EST - 2 months ago

Charles River Laboratories International, Inc. (CRL) Presents at Evercore 8th Annual Healthcare Conference Transcript

Dec 1, 2025, 3:42 PM EST - 2 months ago

HALPER SADEH LLC ENCOURAGES CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Dec 1, 2025, 8:00 AM EST - 2 months ago

Charles River Laboratories to Present at Evercore Healthcare Conference

Nov 21, 2025, 8:35 AM EST - 2 months ago

Madison Small Cap Fund Q3 2025 Portfolio Activity

EXP HXL SAIA

Nov 18, 2025, 12:58 PM EST - 2 months ago

Charles River Laboratories International, Inc. (CRL) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 18, 2025, 8:00 AM EST - 2 months ago

SOLVE and Charles River Development Partner to Deliver Integrated Fixed Income Pricing for Investment Managers

Nov 17, 2025, 8:00 AM EST - 2 months ago

Charles River Laboratories to Present at Jefferies Global Healthcare Conference

Nov 5, 2025, 2:21 PM EST - 3 months ago

Charles River Laboratories International, Inc. (CRL) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 1:38 PM EST - 3 months ago

Charles River Beat Expectations But Why Is The Stock Falling?

Nov 5, 2025, 12:33 PM EST - 3 months ago

Charles River: Mixed Q3 As Strategic Review Disappoints

Nov 5, 2025, 7:34 AM EST - 3 months ago

Charles River raises annual profit forecast on stabilizing biotech demand

Nov 5, 2025, 7:01 AM EST - 3 months ago

Charles River Laboratories Provides Update on Strategic Review

Nov 5, 2025, 7:00 AM EST - 3 months ago

Charles River Laboratories Announces Third-Quarter 2025 Results

Oct 24, 2025, 10:22 AM EDT - 3 months ago

Halper Sadeh LLC Encourages Charles River Laboratories International, Inc. Shareholders to Contact the Firm to Discuss Their Rights

Oct 22, 2025, 8:00 AM EDT - 3 months ago

Charles River and the Francis Crick Institute Combine Expertise in Antibody-Drug Conjugate Development

Oct 20, 2025, 8:00 AM EDT - 3 months ago

Charles River and X-Chem Announce Strategic Collaboration to Enhance Hit Identification Capabilities

Oct 15, 2025, 8:00 AM EDT - 3 months ago

Charles River Announces Scientific Advisory Board to Drive Alternative Method Innovation and Adoption

Oct 14, 2025, 8:00 AM EDT - 4 months ago

Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call

Oct 8, 2025, 8:00 AM EDT - 4 months ago

Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing

Oct 7, 2025, 7:22 AM EDT - 4 months ago

Why Charles River Stock May Struggle In Its Final Phase

Sep 16, 2025, 7:05 AM EDT - 5 months ago

Charles River Laboratories Announces Chief Financial Officer Transition

Sep 11, 2025, 8:00 AM EDT - 5 months ago

Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer

Sep 10, 2025, 12:40 PM EDT - 5 months ago

Charles River Laboratories International, Inc. (CRL) Presents At Baird 2025 Global Healthcare Conference (Transcript)

Sep 9, 2025, 1:09 PM EDT - 5 months ago

Charles River Laboratories International, Inc. (CRL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Sep 8, 2025, 8:00 AM EDT - 5 months ago

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

Sep 3, 2025, 8:00 AM EDT - 5 months ago

Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences

Aug 26, 2025, 8:00 AM EDT - 5 months ago

Charles River Joins EASYGEN Consortium, Supports Development of Bedside CAR-T Manufacturing

Aug 6, 2025, 1:30 PM EDT - 6 months ago

Charles River Laboratories International, Inc. (CRL) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 12:50 PM EDT - 6 months ago

Charles River Sees Limited Impact From NIH Cuts, Tariffs, Drug Pricing

Aug 6, 2025, 12:47 PM EDT - 6 months ago

Charles River: Margin Fears Outweigh Solid Q2

Aug 6, 2025, 7:55 AM EDT - 6 months ago

Charles River raises profit forecast on growing demand for drug development services

Aug 6, 2025, 7:00 AM EDT - 6 months ago

Charles River Laboratories Announces Second-Quarter 2025 Results

Jul 22, 2025, 8:00 AM EDT - 7 months ago

Charles River Joins Elly's Team to Drive Rare Disease Gene Therapy Development

Jul 15, 2025, 8:00 AM EDT - 7 months ago

Charles River Laboratories Schedules Second-Quarter 2025 Earnings Release and Conference Call

Jun 16, 2025, 8:00 AM EDT - 8 months ago

Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment

Jun 2, 2025, 8:00 AM EDT - 8 months ago

Charles River Laboratories to Present at William Blair and Jefferies Conferences

May 28, 2025, 8:00 AM EDT - 8 months ago

Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington's Disease Research

May 13, 2025, 8:00 AM EDT - 9 months ago

Charles River Laboratories to Present at Bank of America Health Care Conference

May 10, 2025, 8:49 AM EDT - 9 months ago

Activist Elliott reaches key agreement with Charles River. Here are three ways to create value

May 7, 2025, 5:31 PM EDT - 9 months ago

S&P 500 Gains & Losses Today: Stocks Gain in Volatile Session as Markets React to Fed Meeting, Trump Trade Comments

May 7, 2025, 2:46 PM EDT - 9 months ago

Charles River Laboratories International, Inc. (CRL) Q1 2025 Earnings Call Transcript

Sam201 Feb. 2 at 2:33 PM

$CRL short more!

0 · Reply

IN0V8 Jan. 22 at 3:28 PM

$CRL TD Cowen raises target to $251 from $197

0 · Reply

IN0V8 Jan. 20 at 10:10 PM

$CRL Jefferies raises PT to $255 from $205

0 · Reply

Funxs Jan. 16 at 2:55 PM

0 · Reply

BullishBecky Jan. 13 at 6:28 PM

$CRL

0 · Reply

IN0V8 Jan. 13 at 6:04 PM

$CRL Opportunity Baird raises target price to $231 from $224

0 · Reply

erevnon Jan. 13 at 3:49 PM

Evercore ISI Group maintains Charles River $CRL at Outperform and raises the price target from $250 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

Sam201 Jan. 8 at 3:34 PM

$CRL shorting some more.

0 · Reply

AlphaBull_10M Jan. 6 at 9:35 PM

0 · Reply

kareem1988 Jan. 6 at 12:33 PM

0 · Reply

John_Wick1234 Dec. 30 at 10:40 AM

$CRL Ascending Channel with good volume.

0 · Reply

ApogeeArc Dec. 27 at 12:54 PM

$CRL Short‑term swings mask the deeper question: can discipline hold; commercial execution has to tighten in upcoming quarters — any stumble could quickly widen valuation discounts. Upside exists, but credibility must lead the way.

0 · Reply

OfficialStocktwitsUser Dec. 25 at 2:27 AM

$CRL RSI: 76.98, MACD: 7.0817 Vol: 9.07, MA20: 190.28, MA50: 181.59 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

ZacksResearch Dec. 18 at 3:18 PM

Is $CRL positioned for growth despite fierce competition? 🤔 Charles River’s large research model product revenues thrived with a 6.5% organic revenue boost in Q3 2025, but macro headwinds and a competitive landscape loom large. However, its strategic partnerships and strong solvency offer a cushion. 📈 Opportunity assessment here 👉 https://www.zacks.com/stock/news/2806011/should-you-continue-to-hold-crl-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2806011-body-25419&ADID=SYND_STOCKTWITS_TWEET_2_2806011_BODY_25419

0 · Reply

JarvisFlow Dec. 18 at 1:13 PM

Mizuho updates rating for Charles River ( $CRL ) to Neutral, target set at 174 → 200.

0 · Reply

ZacksResearch Dec. 18 at 12:41 PM

Hold or trim $CRL — is now the moment of truth? ⚖️ The question isn’t about buying — it’s whether CRL still earns its spot in your portfolio for now, signaling a potential inflection point investors can’t ignore. See the full hold-or-sell breakdown here 👉 https://www.zacks.com/stock/news/2806011/should-you-continue-to-hold-crl-stock-in-your-portfolio-for-now?cid=sm-stocktwits-2-2806011-teaser-25351&ADID=SYND_STOCKTWITS_TWEET_2_2806011_TEASER_25351

0 · Reply

JarvisFlow Dec. 15 at 8:58 PM

Barclays updates rating for Charles River ( $CRL ) to Overweight, target set at 210 → 215.

0 · Reply

RunnerSignals Dec. 15 at 8:22 PM

$ASH $CRL $CVX stock upgrades today with near-term gains possible https://stocksrunner.com/news/2025-12-15-stock-upgrades-today-show-top-picks

0 · Reply

erevnon Dec. 15 at 7:48 PM

JP Morgan maintains Charles River $CRL at Neutral and raises the price target from $165 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

JarvisFlow Dec. 15 at 7:07 PM

JP Morgan has updated their rating for Charles River ( $CRL ) to Neutral with a price target of 190.

0 · Reply

madisonclark03 Dec. 11 at 7:44 PM

$CRL Mainz Biomed has the perfect trap setup for late shorts: they see a dead $1 stock, but once 1.12–1.15 breaks, borrow dries up and the squeeze writes the story 📈😈

0 · Reply

Sam201 Dec. 10 at 8:34 PM

$CRL short this!

1 · Reply

Market Cap	10.36B
Revenue (ttm)	4.05B
Net Income (ttm)	22.20M
EPS (ttm)	N/A
PE Ratio	20.06
Forward PE	19.81
Profit Margin	0.55%
Debt to Equity Ratio	0.64

Volume	402,900
Avg Vol	697,222
Day's Range	N/A - N/A
Shares Out	49.22M
Stochastic %K	30%
Beta	1.61
Analysts	Strong Sell
Price Target	$221.64